TherapeuticsMD Inc. Stock Underperforms Monday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.TherapeuticsMD Inc. (TXMD) shares fell 1.50% to $1.97 on Monday, underperforming competitors like AbbVie during a broad market decline. This marks the second consecutive day of losses for the stock, which remains 33.22% below its 52-week high. Trading volume was significantly lower than the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of TherapeuticsMD Inc. (TXMD) slid 1.50% to $1.97 Monday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 1.55% to 25,873.18 and Dow Jones Industrial Average falling 0.26% to 52,498.64.
This was the stock's second consecutive day of losses.
TherapeuticsMD Inc. closed 33.22% short of its 52-week high of $2.95, which the company reached on January 27th.
The stock underperformed when compared to some of its competitors Monday, as AbbVie Inc. (ABBV) fell 0.03% to $248.00.
Trading volume (4,355) remained 38,910 below its 50-day average volume of 43,265.
Data source: Dow Jones Market Data, FactSet. Data compiled July 13, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-13-26 1730ET